1 Healthcare Stock to Watch Closely This Week and 2 Encountering Obstacles

Healthcare Sector: Innovation and Market Performance

Healthcare organizations are redefining industry standards through breakthroughs in areas such as pharmaceutical research and digital health solutions. Companies driving these medical innovations have seen heightened demand, resulting in impressive momentum. Over the last six months, the sector has achieved an 8.6% increase, outperforming the S&P 500 by 3.5 percentage points.

However, investors should remain cautious. The healthcare field is subject to strict regulations, and shifts in policy can have significant consequences for businesses. With this in mind, we highlight one robust healthcare stock worth considering, along with two that may be best avoided.

Healthcare Stocks to Consider Selling

Brookdale (BKD)

Market Capitalization: $3.58 billion

Brookdale Senior Living (NYSE:BKD) manages a network of more than 650 communities, providing services to about 59,000 residents in 41 states. Their offerings include independent and assisted living, memory care, and continuing care retirement communities.

Reasons for Caution with BKD:

• Annual sales have declined by 2% over the past five years, indicating unfavorable market dynamics during this period.
• Projections suggest a 5.2% drop in sales over the coming year as demand wanes.
• The company’s high net-debt-to-EBITDA ratio of 11× raises concerns about potential forced asset sales or dilutive financing if performance deteriorates.

Brookdale shares are currently priced at $15.07, with a forward EV-to-EBITDA multiple of 17.3.

Avantor (AVTR)

Market Capitalization: $5.9 billion

With a history dating back to 1904, Avantor (NYSE:AVTR) supplies essential products, materials, and services to clients in biopharma, healthcare, education, and advanced technology sectors, supporting nearly every phase of scientific research and production.

Why We’re Steering Clear of AVTR:

• Organic revenue growth has lagged expectations over the past two years, suggesting a need for improvements in product offerings, pricing, or sales strategies.
• Analysts anticipate stagnant revenue in the next year, pointing to subdued demand.
• Earnings per share have remained flat over the last five years, underperforming the broader sector.

Avantor trades at $8.76 per share, reflecting a forward P/E ratio of 11.1.

Healthcare Stock Worth Watching

Boston Scientific (BSX)

Market Capitalization: $107.2 billion

Founded in 1979, Boston Scientific (NYSE:BSX) is dedicated to advancing minimally invasive medical technology. The company designs and manufactures devices used in procedures across cardiovascular, urological, neurological, and gastrointestinal specialties.

What Makes BSX Stand Out?

• The company’s core business has achieved an average organic revenue growth of 16.6% over the past two years, reducing the need for risky acquisitions.
• Over the last five years, earnings per share have grown at an annual rate of 26%, outpacing revenue growth and boosting profitability.
• Free cash flow margin has increased by 7 percentage points in five years, providing more capital for growth initiatives, share buybacks, or dividends.

Boston Scientific is currently valued at $72.60 per share, with a forward P/E of 21.3.

Stocks That Deserve Even More Attention

Don’t Miss: This Week’s Top 6 Stock Picks

The current market environment is rapidly distinguishing high-quality stocks from overpriced ones, with AI-driven shifts impacting entire sectors unexpectedly. In such a fast-moving market, a simple list of good companies isn’t enough.

Our AI-powered system identified Palantir before its 1,662% surge, AppLovin ahead of its 753% rally, and Nvidia prior to its 1,178% climb. Every week, it highlights six new stocks that meet the same rigorous criteria.

Some of our 2020 selections, like Nvidia (up 1,326% from June 2020 to June 2025) and lesser-known names such as Comfort Systems (delivering a 782% five-year return), have delivered remarkable results.